Financials

	2024	2025
Net sales	492K 426K 402K 365K 685K 47.16M 690K 4.8M 1.85M 23.92M 1.85M 1.81M 76.05M	89K 77.12K 72.78K 66.02K 124K 8.53M 125K 869K 335K 4.33M 334K 327K 13.76M
Net income	-1.04M -901K -850K -772K -1.45M -99.68M -1.46M -10.16M -3.91M -50.57M -3.91M -3.82M -161M	-3.98M -3.45M -3.25M -2.95M -5.53M -381M -5.57M -38.83M -14.96M -193M -14.93M -14.6M -615M
Net Debt	6.22M 5.39M 5.08M 4.61M 8.65M 596M 8.71M 60.72M 23.4M 302M 23.35M 22.84M 961M	911K 789K 745K 676K 1.27M 87.32M 1.28M 8.9M 3.43M 44.3M 3.42M 3.35M 141M

* Estimated data More financial data

Company Profile

DXI Capital Corp. is a Canada-based company. The Company has no active operations. It does not generate revenue from its operations. The Companyâ€™s wholly owned subsidiary is 0855524 B.C. Ltd.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-09-14	$0.1900	0.00%	38,100
26-09-11	$0.1900	-5.00%	26,500
26-09-10	$0.2000	0.00%	47,500
26-09-09	$0.2000	+5.26%	22,500
26-09-08	$0.1900	-5.00%	3,500

Delayed Quote Toronto S.E.

More quotes

Delayed Toronto S.E. 14:31:40 2026-09-14 EDT			5-day change	1st Jan Change
0.1900 ^CAD	0.00%		0.00%	-36.67%

09-11	VVT Med Raises Total of $1.9 Million After Closing Second Tranche of Private Placement	MT
09-01	Vvt Med Inc. and Dermworks Enter Distribution and Evaluation Agreement for Sclerosafe in Portugal	CI

Market Cap	10.49M 9.09M 8.58M 7.78M 14.6M 1.01B 14.71M 102M 39.49M 510M 39.41M 38.54M 1.62B	P/E 2024 *	-	P/E 2025	-2.71x
Enterprise Value	11.4M 9.88M 9.33M 8.46M 15.87M 1.09B 15.98M 111M 42.91M 554M 42.83M 41.89M 1.76B	EV / Sales 2024 *	-	EV / Sales 2025	175x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Toronto S.E.	VVTM	Delayed
OTC Markets	VVTMF	Delayed

09-11	VVT Med Raises Total of $1.9 Million After Closing Second Tranche of Private Placement	MT
09-01	Vvt Med Inc. and Dermworks Enter Distribution and Evaluation Agreement for Sclerosafe in Portugal	CI
08-31	VVT Med Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
06-29	VVT Med Inc. Auditor Raises 'Going Concern' Doubt	CI
06-26	VVT Med Signs Exclusive Distribution Deal in Greece Worth About C$1.14 Million	MT
06-26	VVT Med Inc. Enters Exclusive Distribution Agreement With General Chemical Products S.A. For ScleroSafe Platform In Greece	CI
06-11	VVT Med Enters Dominican Republic Market	MT
06-11	VVT Med Inc. Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	CI
05-26	VVT Med Announces First Patients Treated with VVT?s ScleroSafe System in Italy	CI
04-30	VVT Med Inc Announces Positive Clinical Data For ScleroSafe Catheter-Directed Sclerotherapy System	CI
04-27	VVT Med Signs "Largest" European Distribution Agreement to Date	MT

VVT Med Inc. Stock

Stocks

VVTM

CA91841T1084

Medical Equipment, Supplies & Distribution

Valuation: VVT Med Inc.

Chart: VVT Med Inc.

Latest news: VVT Med Inc.

Press Releases: VVT Med Inc.

News in other languages: VVT Med Inc.

Quotes and Performance

Price Extremes

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

09-10	VVT Med Closes Second Tranche of Private Placement of Units; Over $1.8M in Total Proceeds Raised	AQ
09-01	VVT Med Advances Portugal Market Entry as Dermworks Begins ScleroSafe® Market Evaluation and Announces Corporate Updates	AQ
08-21	VVT Med Announces Debt Settlement and Equity Incentive Grants to Strengthen Capital Structure	AQ
06-26	VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece	AQ
06-12	VVT Med Provides Update on Management Cease Trade Order	AQ

11-26	VVT Medical Inc. (VVTM) ouvre les marchés
23-11-23	Sopra Steria Group: Willy il Coyote cerca di tenere il passo con Bip Bip
23-11-23	Sopra Steria Group: Coyote intenta seguir el ritmo de Bip Bip
23-11-23	Sopra Steria Group : le Coyote tente de suivre Bip Bip

1 month	-20.83%
3 months	-36.67%
6 months	-9.52%
Current year	-36.67%

1 week	0.15	0.2
1 month	0.15	0.27
Current year	0.15	0.45
1 year	0.15	0.45
3 years	0.15	0.56
5 years	0.15	0.56
10 years	0.15	0.56

Date	Insider	Type	Main position	% Market Cap.
4/28/26	Erez Tetro	Other	Chief Executive Officer	0%
4/27/26	Yair Aloni	Other	Chairman	0%
4/27/26	Yair Aloni	Other	Chairman	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VVT MED INC.	0.00%	0.00%	-52.50%	-	10.49M
ABBOTT LABORATORIES	+1.02%	-2.26%	-21.47%	+0.47%	176B
MEDTRONIC PLC	+3.08%	+1.46%	+0.33%	+14.37%	116B
CENCORA, INC.	+1.92%	+0.61%	+12.10%	+84.56%	61.36B
HOYA CORPORATION	-1.15%	-7.08%	+5.83%	+39.93%	49.42B
BECTON, DICKINSON AND COMPANY	+2.61%	+1.75%	-1.89%	-31.13%	48.44B
DEXCOM, INC.	+1.98%	+0.14%	+12.00%	-16.64%	31.33B
MEDLINE INC.	+0.89%	-5.71%	-	-	28.54B
WEST PHARMACEUTICAL SERVICES, INC.	+2.64%	+5.26%	+38.05%	-10.65%	24.37B
TERUMO CORPORATION	+0.73%	-6.97%	-12.66%	+4.70%	21.57B
Average	+1.37%	-4.93%	-2.25%	+10.70%	55.78B
Weighted average by Cap.	+1.59%	-4.84%	-3.36%	+12.71%